C, R., C, L., E, G., M, H., S, A., B, C., . . . S, C. (2018). Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload. European journal of haematology. https://doi.org/10.1111/ejh.13088
Chicago Style (17th ed.) CitationC, Rose, et al. "Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-dependent Patients with Low-risk MDS and Iron Overload." European Journal of Haematology 2018. https://doi.org/10.1111/ejh.13088.
MLA (9th ed.) CitationC, Rose, et al. "Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-dependent Patients with Low-risk MDS and Iron Overload." European Journal of Haematology, 2018, https://doi.org/10.1111/ejh.13088.